Fees paid to USFDA for Approval of Medicament is Service under Finance Act, liable to Service Tax: CESTAT [Read Order]

Fees -paid - USFDA - Approval - Medicament - Service - Finance- Act-liable - Service -Tax-CESTAT-TAXSCAN

The Ahmadabad bench of Customs, Excise and Service Tax Appellate Tribunal (CESTAT) held that the fees paid by Cadila Pharmaceuticals Ltd (the appellant) to the United States Food and Drug Administration (USFDA) can be considered as service under the Finance Act (mention the year) and was leviable by the CST of Ahmedabad. The appeal was…

Your free access to Taxscan has Expired

To read the article, get a premium account.

Taxscan Premium

Why should you subscribe?
  • Enjoy our website without interruptions from advertisements
  • Receive Daily newsletters
  • Receive realtime Telegram/Whatsapp news updates
  • Download original Judgements / Order / Notifications / Circulars, etc
  • Enjoy exclusive entry fees to Simplified series. (Webinars, Seminars, masterclasses, etc.)
  ₹1199 + GST for 1 year

Subscribe Now

taxscan-loader